1. Home
  2. LBRDP vs CGEN Comparison

LBRDP vs CGEN Comparison

Compare LBRDP & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LBRDP
  • CGEN
  • Stock Information
  • Founded
  • LBRDP N/A
  • CGEN 1993
  • Country
  • LBRDP United States
  • CGEN Israel
  • Employees
  • LBRDP 1900
  • CGEN N/A
  • Industry
  • LBRDP Cable & Other Pay Television Services
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LBRDP Telecommunications
  • CGEN Health Care
  • Exchange
  • LBRDP Nasdaq
  • CGEN Nasdaq
  • Market Cap
  • LBRDP N/A
  • CGEN 167.4M
  • IPO Year
  • LBRDP N/A
  • CGEN 2000
  • Fundamental
  • Price
  • LBRDP $25.00
  • CGEN $1.73
  • Analyst Decision
  • LBRDP
  • CGEN
  • Analyst Count
  • LBRDP 0
  • CGEN 0
  • Target Price
  • LBRDP N/A
  • CGEN N/A
  • AVG Volume (30 Days)
  • LBRDP N/A
  • CGEN 265.3K
  • Earning Date
  • LBRDP N/A
  • CGEN 08-05-2025
  • Dividend Yield
  • LBRDP N/A
  • CGEN N/A
  • EPS Growth
  • LBRDP N/A
  • CGEN N/A
  • EPS
  • LBRDP N/A
  • CGEN N/A
  • Revenue
  • LBRDP N/A
  • CGEN $27,589,000.00
  • Revenue This Year
  • LBRDP N/A
  • CGEN N/A
  • Revenue Next Year
  • LBRDP N/A
  • CGEN $173.80
  • P/E Ratio
  • LBRDP N/A
  • CGEN N/A
  • Revenue Growth
  • LBRDP N/A
  • CGEN N/A
  • 52 Week Low
  • LBRDP N/A
  • CGEN $1.13
  • 52 Week High
  • LBRDP N/A
  • CGEN $2.66
  • Technical
  • Relative Strength Index (RSI)
  • LBRDP 60.46
  • CGEN 57.84
  • Support Level
  • LBRDP $24.84
  • CGEN $1.62
  • Resistance Level
  • LBRDP $25.19
  • CGEN $1.81
  • Average True Range (ATR)
  • LBRDP 0.18
  • CGEN 0.08
  • MACD
  • LBRDP 0.03
  • CGEN -0.00
  • Stochastic Oscillator
  • LBRDP 73.36
  • CGEN 65.22

About LBRDP Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: